These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1139664)

  • 21. Regulation of immune response in cancer by plasma: the postulated role of transcortin.
    Amaral L; Werthamer S
    Ann Clin Lab Sci; 1974; 4(6):435-40. PubMed ID: 4429341
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunochemical and immunopathological studies of trophoblast antigens. Preliminary results using a crude placental extract.
    Park HS; Oi VT; Yokoyama MM
    Hawaii Med J; 1973; 32(6):385-8. PubMed ID: 4767695
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
    Ablin RJ
    Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
    [No Abstract]   [Full Text] [Related]  

  • 24. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 26. Disarmed anti-malignin antibody in human cancer.
    Bogoch S; Bogoch ES
    Lancet; 1979 May; 1(8123):987. PubMed ID: 87667
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immune surveillance in neoplasms].
    Schneeweiss U
    Z Exp Chir; 1974; 7(4):204-15. PubMed ID: 4440030
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical aspects of cancer immunity.
    Moore GE
    Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
    [No Abstract]   [Full Text] [Related]  

  • 29. The secretory immunologic system of fowl. IV. Serum and salivary immunoglobulins in normal, agammaglobulinemic and dysgammaglobulinemic chickens.
    Leslie GA; Martin LN
    Int Arch Allergy Appl Immunol; 1974; 46(6):834-41. PubMed ID: 4210279
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of ionizing radiations on certain parameters of the immune status of cancer patients].
    Solbes Solbes R; Sánchez Vicente A; García-Talavera JR; Soler Ripoll JJ
    Rev Esp Oncol; 1982; 29(4):755-64. PubMed ID: 6765422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cancer recognition (CARE) antibody test.
    Thornthwaite JT; McDuffee EC; Harris RB; Secor McVoy JR; Lane IW
    Cancer Lett; 2004 Dec; 216(2):227-41. PubMed ID: 15533599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies in breast cancer.
    Lentino JA
    Allergol Immunopathol (Madr); 1975; 3(5):279-88. PubMed ID: 1227278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
    Kirkwood JM; Vlock DR
    Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of immunoglobulins IgG, IgA and IgM in the serum of pemphigus vulgaris and bullous patients].
    Kratochvíl F; Vlasín Z
    Dermatol Monatsschr; 1974 Dec; 160(12):990-7. PubMed ID: 4618523
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of the quantitative determination of IgG, IgA and IgM globulins in the sera of patients with chronic liver diseases].
    Kallai L; Keler-Backa M; Hadzić N; Knezević S
    Acta Med Iugosl; 1975; 29(3):191-8. PubMed ID: 1146598
    [No Abstract]   [Full Text] [Related]  

  • 39. Gm and Km allotypes, immune response and disease susceptibility.
    Whittingham S; Propert DN
    Monogr Allergy; 1986; 19():52-70. PubMed ID: 3093851
    [No Abstract]   [Full Text] [Related]  

  • 40. [Delayed hypersensitivity as a result of successful chemotherapy of neoplasms].
    Jedrzejczak WW
    Wiad Lek; 1980 Apr; 33(7):547-53. PubMed ID: 6967240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.